Faron Pharmaceuticals - Innovatiivisia lääketieteen ratkaisuja (Osa 2)

This is the last article of the year.

This time, a broader range of topics is discussed, but HCM bonds still remain central due to circumstances. Other topics include:

  • Liquidity situation
  • August cash repayment and its background
  • Early repayment of the IPF loan and its true reason
  • Pledging of own shares
  • Death spiral bonds and the optimal strategy for maximizing their value
  • HCM Bonds conversion price reset mechanism and its effects on various financing solutions
  • Valuation of HCM bonds
  • The price of the second HCM bond relative to a directed share issue
  • What are licensing agreements about?
  • Why a global licensing agreement is unlikely
  • What inaccuracies are present in analysts’ calculations and how you can arrive at more accurate results

I wish everyone the most peaceful Christmas season!

31 Likes